Home › Biogen Idec's TECFIDERA (Dimethyl Fumarate) Approved In US As A First-Line Oral Treatment For Multiple Sclerosis
 

Keywords :   


Biogen Idec's TECFIDERA (Dimethyl Fumarate) Approved In US As A First-Line Oral Treatment For Multiple Sclerosis

2013-03-27 17:10:00| dairynetwork News Articles

Recently Biogen Idec announced that the U.S. Food and Drug Administration (FDA) has approved TECFIDERA (dimethyl fumarate), a new first-line oral treatment for people with relapsing forms of multiple sclerosis (MS).

Tags: multiple treatment approved oral

Category:Agriculture and Forestry

Latest from this category

All news
16.11This Week in Agribusiness, Nov. 16, 2024
16.11This Week in Agribusiness, Nov. 16, 2024
15.11Global beef roundup: Focus on Brazil, Part 2
15.112024 NAPRRS/NC229 session to address emerging swine diseases
15.11Beef, dairy producers invited to Purdue Calving Academy
15.11The long grind
15.11JBS reports strong Q3 financial results
15.11U.S. consumers meat preferences are changing
Agriculture and Forestry »
16.11SRAM Level T
16.11 alone at home t XL
16.11S.H.Figuarts()
16.112
16.11QMSV XX Meilin 40cm
16.11LP
16.11The Study of COMME des GARCONS SWITCH
16.11
More »